SCHEMBL4039833

SCHEMBL4039833

COc1ccc2c(c1)NC(c1ccc(F)cc1)(C(C(=O)NC1CCCCC1)C1CCCCC1)N2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
EPHX2 P34913 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.40
EPHX1 P07099 1/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 3/20 0.40
CNR1 P21554 2/20 0.40
CNR2 P34972 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP3A4 P08684 2/20 0.40
HPGD P15428 1/20 0.40
CYP2C9 P11712 1/20 0.40
HTT P42858 1/20 0.40
RECQL P46063 1/20 0.40
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4042532 1.00 NPC1 (0.42) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4034659 0.94 NPC1 (0.43) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4045000 0.91 NR1H4 (0.48) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4037444 0.91 NR1H4 (0.48) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4038480 0.91 NR1H4 (0.48) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4041388 0.88 NR1H4 (0.40) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4034364 0.88 NR1H4 (0.40) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4041511 0.88 LMNA (0.44) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4035053 0.88 LMNA (0.44) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL4038748 0.88 LMNA (0.44) NPC1RAB9AMEN1KMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed